DALLAS, TX--(Marketwire - March 16, 2010) -
BioTech Medics, Inc. (PINKSHEETS: BMCS
) announced that it has signed a major USA distribution agreement with A.J.S. Enterprises, Inc. of Dallas, Texas for BioTech's SHBAN™ Alcohol Free Hand Sanitizer and Antiseptic.
"AJS is well established, has a network of over ninety sources and has distributed Duracell® Batteries and other major name brands throughout the USA to major retail and wholesale outlets for over two decades. We look forward to AJS representing SHBAN," said Keith Houser, CEO.
It is projected that AJS will be placing SHBAN with Albertsons, Randalls, Krogers, Brookshires, Safeway, HEB, Whole Foods and CVS Pharmacies throughout Texas starting in May and June. A major total USA distribution of SHBAN is scheduled this Fall at the peak of flu, allergy and cold season.
SHBAN has been tested extensively for over 12 years. Its active ingredient is FDA approved. SHBAN was invented by Edward J. Cragoe, Jr. PhD. who has invented over 19 drugs in his career.
BioTech announced last month they have begun pre-production of SHBAN two minute, sixty second and thirty second direct response TV and radio commercials for nationwide. BioTech has retained former Miss Arizona (1989) LeeAnne Locken. Ms. Locken co-starred with Golden Globe actress Sandra Bullock in "Miss Congeniality," the 2000 movie. The ads are to create brand awareness and sales.
SHBAN is a bio-degradable product superior to most anti-bacterial antiseptics because 1) SHBAN is longer lasting. SHBAN does not evaporate within 15 seconds after application and cease working (like alcohol gels); 2) SHBAN is non-toxic when used as directed on humans and animals (over 22,000 alcohol poisoning calls have been placed to the Poison Control Center within the past 3 years); 3) SHBAN is non-staining, non-bleaching; 4) SHBAN is non-flammable and 5) SHBAN has no harmful or toxic odors. Most hand sanitizer products cannot make all of these claims.
SHBAN is protected under US Letters of Patent #5,514,808, #5,574,050, #5,679,711 and #5,585,391 and pending international patent. SHBAN is a trademark of BioTech Medics, Inc.
Safe Harbor: Forward-Looking Statements
This release contains forward-looking statements within the meaning of The Private Securities Litigation Reform Act of 1995 (the "Act"). The SHBAN statements above have not been evaluated by the FDA. SHBAN is not intended to diagnose, treat or cure any disease.